Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide

Cytokine. 2013 Jun;62(3):426-32. doi: 10.1016/j.cyto.2013.03.025. Epub 2013 Apr 16.

Abstract

Large amounts of anti-inflammatory mediators, such as interleukin (IL)-10, are produced and found early in the course of sepsis. We explore the role of IL-10 on neutrophil (PMN) activation/function using an in vitro model. Isolated human PMN were pre-incubated with lipopolysaccharide (LPS) and/or IL-10 for 18h. Subsequently, a second LPS exposure was performed and CD11b and CD66b up-regulation, and the reactive oxygen species (ROS) generation were measured 2h later. We found that IL-10 prevented PMN activation and the secretion of TNF-α and IL-8 induced by the first LPS contact. In the absence of IL-10, a second LPS exposure induced additive effects that were prevented by IL-10. Only ROS generation was highly affected by the blockade of PMN-secreted TNF-α or IL-8. Additionally, IL-10 prevented other possible mechanisms of LPS priming. Therefore, IL-10 modulates PMN activation preventing autocrine activating loops and priming mechanisms, rendering PMN less responsive to a second LPS exposure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autocrine Communication / drug effects
  • Cell Degranulation / drug effects
  • Cell Separation
  • Humans
  • Interleukin-10 / metabolism*
  • Interleukin-8 / metabolism
  • Lipopolysaccharides / pharmacology*
  • Neutrophil Activation / drug effects*
  • Neutrophils / drug effects*
  • Neutrophils / metabolism*
  • Neutrophils / physiology
  • Reactive Oxygen Species / metabolism
  • Teichoic Acids / pharmacology

Substances

  • IL10 protein, human
  • Interleukin-8
  • Lipopolysaccharides
  • Reactive Oxygen Species
  • Teichoic Acids
  • Interleukin-10
  • lipoteichoic acid